How does octreotide stop esophageal varices?

Published by Anaya Cole on

How does octreotide stop esophageal varices?

Octreotide reduces portal and variceal pressures as well as splanchnic and portal-systemic collateral blood flows [2]. It also prevents postprandial splanchnic hyperemia in patients with portal hypertension [3] and lowers gastric mucosal blood flow in normal and portal hypertensive stomachs [4].

How does octreotide work in varices?

Variceal bleeding: Octreotide decreases the inflow of blood to portal system by constricting the splanchnic arterioles and significantly reduces intravariceal pressure.

Is octreotide used for esophageal varices?

Despite the availability of improved therapy, mortality continues to be high. Octreotide has been shown to be at least as effective as vasopressin in the treatment of bleeding varices, with fewer and less severe systemic adverse effects.

How does octreotide help with GI bleed?

Sandostatin (octreotide acetate) may help treat certain types of bleeding in the gastrointestinal (GI) tract through various mechanisms, including its ability to: Reduce blood flow in the gastrointestinal system. Inhibit stomach acids. Decrease the clumping of platelets.

How does octreotide work?

It slows down or stops the production of a number of hormones such as insulin and gut hormones. It also controls the emptying of the stomach and bowel. Octreotide is a synthetic version of somatostatin (a somatostatin analogue) and slows down the production of hormones.

How does octreotide decrease portal blood flow?

Octreotide inhibits the release of glucagon, which is a splanchnic vasodilator. It therefore reduces splanchnic blood flow and portal venous pressure.

Is octreotide effective in the treatment of esophageal varices?

These discrepancies have led some experts to conclude that there is currently insufficient evidence to support the use of octreotide in acute variceal bleeding. Approach to the management of bleeding esophageal varices: role of somatostatin.

What is the PMID of octreotide in variceal bleeding?

PMID: 8206396 Octreotide in variceal bleeding. A K Burroughs Author informationCopyright and License informationDisclaimer Hepato-biliary and Liver Transplantation Unit, Royal Free Hospital, London. Copyright notice This article has been cited byother articles in PMC. Abstract Bleeding from oesophageal varices has a high death rate.

Is there a difference between sclerotherapy and octreotide therapy for variceal bleeding?

This study had fewer patients with an index (i.e., first) variceal bleed in the octreotide group vs. the sclerotherapy group (38% vs. 58%; P < 0.05) and lacked investigator blinding.

What is the difference between somatostatin and octreotide for variceal hemorrhage?

Somatostatin or octreotide versus endoscopic sclerotherapy in acute variceal haemorrhage: a meta-analysis study. Octreotide is a synthetic octapeptide with pharmacologic actions similar to the endogenous hormone somatostatin.